Summary

Associate Professor, Cancer Immunology

The Center for Advanced Innate Cell Therapy (AICT) within the Texas Children's Cancer and Hematology Center at Baylor College of Medicine (BCM) has an opening for a tenure-track or tenured Associate Professor to lead an innovative research program in synthetic immunology and development of innovative cell therapies for cancer. AICT provides a highly competitive recruitment package including a start-up funding, recently renovated laboratory space, and highly supportive academic environment. Among the many core facilities available at BCM are ones supporting cGMP manufacturing of cell and gene therapy products, Single Cell Genomics, Metabolomics, Analytical Biochemistry, Biostatistics, Pathology, Flow Cytometry, and the state-of-the-art Microscopy. The successful candidate will join a team of laboratory and clinical investigators at the AICT who work collaboratively on the development of safe and effective therapies for childhood cancer using natural and engineered properties of the immune system.

Research areas of interested candidates may include:
• Adoptive cell therapy
• Immunobiology of anti-tumor immune effector cells
• Synthetic immune receptors
• Cell signaling, specifically as pertains to synthetic receptors
• Natural and engineered transcriptional circuits in immune effector cells
• Epigenetic reprogramming of immune effector cells

The successful candidate is expected to be an established leader in her/his field of research, with an exceptionally strong record of publications in the top-tier peer-reviewed journals, and sustained extramural funding from NIH, NSF, and other competitive sources.

Minimum qualifications:

PhD, MD, or PhD/MD degree in a relevant scientific field (e.g. immunology, molecular biology, cancer biology, molecular oncology)
At least three years in the rank of Assistant Professor
Track record of cutting-edge research with an outstanding record of scientific accomplishments
Sustained federal research funding